IXJ Holdings Information

IXJ is an equity ETF with a total of 131 individual holdings. The top holdings are Eli Lilly and Company stock at 9.88%, Johnson & Johnson at 7.33%, AbbVie at 5.18%, Roche Holding AG at 4.01%, and AstraZeneca at 3.88%.

Total Holdings

131

Top 10 Percentage

46.07%

Asset Class

Equity

ETF Category

Health

Assets

4.09B

PE Ratio

22.88

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	9.88%	401,643
2	JNJ	Johnson & Johnson	7.33%	1,218,604
3	ABBV	AbbVie Inc.	5.18%	893,898
4	SWX: ROG	Roche Holding AG	4.01%	355,410
5	LON: AZN	AstraZeneca PLC	3.88%	784,372
6	SWX: NOVN	Novartis AG	3.86%	961,590
7	MRK	Merck & Co., Inc.	3.70%	1,255,356
8	UNH	UnitedHealth Group Incorporated	3.28%	458,212
9	AMGN	Amgen Inc.	2.53%	272,413
10	ABT	Abbott Laboratories	2.43%	877,981
11	TMO	Thermo Fisher Scientific Inc.	2.39%	190,335
12	GILD	Gilead Sciences, Inc.	2.27%	625,137
13	ISRG	Intuitive Surgical, Inc.	2.20%	179,379
14	PFE	Pfizer Inc.	1.88%	2,875,653
15	SYK	Stryker Corporation	1.63%	174,128
16	DHR	Danaher Corporation	1.60%	317,985
17	BMY	Bristol-Myers Squibb Company	1.57%	1,029,622
18	MDT	Medtronic plc	1.52%	648,727
19	CPH: NOVO.B	Novo Nordisk A/S	1.51%	1,611,707
20	VRTX	Vertex Pharmaceuticals Incorporated	1.50%	128,390
21	MCK	McKesson Corporation	1.50%	62,652
22	LON: GSK	GSK plc	1.42%	2,056,464
23	BSX	Boston Scientific Corporation	1.33%	749,772
24	CVS	CVS Health Corporation	1.26%	639,569
25	EPA: SAN	Sanofi	1.24%	546,398

Showing 25 of 131 holdings

Subscribe to see the full list

Activate Now

As of Mar 4, 2026